Abstract
Purpose The study aimed to verify the value of inspiratory muscle training (IMT) in the prevention of post-stroke sarcopenia, and to analyze the effects of IMT on the rehabilitation prognosis, including daily living activities, social regression, balance, and pneumonia, of stroke patients.
Methods A total of 367 patients with a first stroke event were randomly allocated to an experimental group (n =164) and a control group (n =165). Both groups received conventional neurological rehabilitation treatment, and the experimental group also received IMT. After eight weeks of treatment, the incidence of post-stroke sarcopenia and pneumonia were analyzed and compared. The maximum inspiratory pressure (MIP) was assessed using a respiratory resistance trainer, and the Modified Barthel Index (MBI) was used to assess activities of daily living (ADL). The ability to return to society was assessed using the modified Rankin Scale (mRS), the trunk impact scale (TIS) was used to evaluate trunk balance in both groups before and after treatment, and the differences in MIP, MBI, mRs, and TIS between the two groups were analyzed.
Results There were no significant differences in the baseline demographics between the two groups. After eight weeks of treatment, the incidence of post-stroke sarcopenia(P =0.004)and pneumonia (P =0.017) in the experimental group was lower than that in the control group. The trial group performed better than control group in MBI (P =0.02, effect size d =0.3), TIS (P <0.001, effect size d =0.52), MIP (P < 0.001, effect size d =0.4) and mRS (P =0.001, effect size d =0.3) scores after intervention.
Conclusion Early inspiratory muscle training can effectively reduce the incidence of post-stroke sarcopenia and pneumonia and improve the rehabilitation prognosis of patients after stroke.(clinicaltrials.ChiCTR2200057067).
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
clinical trial (code: ChiCTR2200057067)
Funding Statement
QP Z received award from Science and Technology Bureau of Deyang City?project number?2021SZZ078?.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Ethics Committee (approval no. 2021-04-148-K01) of the People's Hospital of Deyang City
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
